Functional and structural characterization of the integrase from the prototype foamy virus

Nucleic Acids Research

Volumn 37, Issue 1, 2009, Pages 243-255

  Valkov, Eugene ^a,c   Gupta, Saumya Shree ^a   Hare, Stephen ^a   Helander, Anna ^a   Roversi, Pietro ^b   Mcclure, Myra ^a   Cherepanov, Peter ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; VIRUS DNA;

ARTICLE; AVIAN SARCOMA VIRUS; CONTROLLED STUDY; DNA STRUCTURE; ENZYME ACTIVE SITE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEQUENCE HOMOLOGY; SPECIES COMPARISON; SPECIES DIFFERENCE; SPUMA VIRUS; STRUCTURE ANALYSIS; VIRAL GENETICS;

AMINO ACID SEQUENCE; ANIMALS; CATALYTIC DOMAIN; CELL LINE; CRYSTALLOGRAPHY; DOGS; ENZYME INHIBITORS; HUMANS; INTEGRASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; SPUMAVIRUS; VIRAL PROTEINS;

ALPHARETROVIRUS; AVIAN SARCOMA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN SPUMARETROVIRUS; LENTIVIRUS; SPUMAVIRUS;

EID: 58549092798     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn938     Document Type: Article

References (84)

1. Asante-Appiah,E. and Skalka,A.M. (1999) HIV-1 integrase: Structural organization, conformational changes, and catalysis. Adv. Virus Res. 52, 351-369.
2. Craigie,R. (2002) Retroviral DNA integration. In Craig,N.L., Craigie,R., Gellert,M. and Lambowitz,A.M. (eds), Mobile DNA II, ASM Press, Washington DC, pp. 613-630.
3. Lewinski,M.K. and Bushman,F.D. (2005) Retroviral DNA integration - mechanism and consequences. Adv. Genet., 55, 147-181.
4. Sherman,P.A. and Fyfe,J.A. (1990) Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. Proc. Natl Acad. Sci. USA, 87, 5119-5123.
5. Enssle,J., Moebes,A., Heinkelein,M., Panhuysen,M., Mauer,B., Schweizer,M., Neumann-Haefelin,D. and Rethwilm,A. (1999) An active foamy virus integrase is required for virus replication. J. Gen. Virol., 80, 1445-1452.
6. Juretzek,T., Holm,T., Gartner,K., Kanzler,S., Lindemann,D., Herchenroder,O., Picard-Maureau,M., Rammling,M., Heinkelein,M. and Rethwilm,A. (2004) Foamy virus integration. J. Virol., 78, 2472-2477.
7. Dyda,F., Hickman,A.B., Jenkins,T.M., Engelman,A., Craigie,R. and Davies,D.R. (1994) Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases. Science 266, 1981-1986.
8. Nowotny,M., Gaidamakov,S.A., Crouch,R.J. and Yang,W. (2005) Crystal structures of RNase H bound to an RNA/DNA hybrid: Substrate specificity and metal-dependent catalysis. Cell, 121, 1005-1016.
9. Nowotny,M. and Yang,W. (2006) Stepwise analyses of metal ions in RNase H catalysis from substrate destabilization to product release. EMBO J. 25, 1924-1933.
10. Yang,W., Lee,J.Y. and Nowotny,M. (2006) Making and breaking nucleic acids: Two-Mg2+-ion catalysis and substrate specificity. Mol. Cell 22, 5-13.
11. Kulkosky,J., Jones,K.S., Katz,R.A., Mack,J.P. and Skalka,A.M. (1992) Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell. Biol., 12 2331-2338.
12. Maignan,S., Guilloteau,J.P., Zhou-Liu,Q., Clement-Mella,C. and Mikol,V. (1998) Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: High level of similarity of the active site with other viral integrases. J. Mol. Biol., 282 359-368.
13. Goldgur,Y., Dyda,F., Hickman,A.B., Jenkins,T.M., Craigie,R. and Davies,D.R. (1998) Three new structures of the core domain of HIV-1 integrase: An active site that binds magnesium. Proc. Natl Acad. Sci. USA, 95, 9150-9154.
14. Bujacz,G., Jaskolski,M., Alexandratos,J., Wlodawer,A., Merkel,G., Katz,R.A. and Skalka,A.M. (1996) The catalytic domain of avian sarcoma virus integrase: Conformation of the active-site residues in the presence of divalent cations. Structure, 4, 89-96.
15. Lovell,S., Goryshin,I.Y., Reznikoff,W.R. and Rayment,I. (2002) Two-metal active site binding of a Tn5 transposase synaptic complex. Nat. Struct. Biol., 9, 278-281.
16. Cai,M., Zheng,R., Caffrey,M., Craigie,R., Clore,G.M. and Gronenborn,A.M. (1997) Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat. Struct. Biol., 4, 567-577.
17. Eijkelenboom,A.P., van den Ent, E.M., Vos, A., Doreleijers, J.F., Hard,K., Tullius,T.D., Plasterk,R.H., Kaptein,R. and Boelens,R. (1997) The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: A three-helix bundle stabilized by zinc. Curr. Biol., 7, 739-746.
18. Eijkelenboom,A.P., Lutzke,R.A., Boelens,R., Plasterk,R.H., Kaptein,R. and Hard,K. (1995) The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nat. Struct. Biol., 2, 807-810.
19. Lodi,P.J., Ernst,J.A., Kuszewski,J., Hickman,A.B., Engelman,A., Craigie,R., Clore,G.M. and Gronenborn,A.M. (1995) Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry, 34, 9826-9833.
20. Vink,C., Oude Groeneger,A.M. and Plasterk,R.H. (1993) Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res., 21, 1419-1425.
21. Engelman,A., Hickman,A.B. and Craigie,R. (1994) The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J. Virol., 68, 5911-5917.
22. Yang,F. and Roth,M.J. (2001) Assembly and catalysis of concerted two-end integration events by Moloney murine leukemia virus integrase. J. Virol., 75, 9561-9570.
23. Aiyar,A., Hindmarsh,P., Skalka,A.M. and Leis,J. (1996) Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: Dependence on both long terminal repeat termini. J. Virol., 70, 3571-3580.
24. Sinha,S. and Grandgenett,D.P. (2005) Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells. J. Virol., 79, 8208-8216.
25. Li,M. and Craigie,R. (2005) Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration. J. Biol. Chem. 280, 29334-29339.
26. Cherepanov,P. (2007) LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res., 35, 113-124.
27. Bushman,F., Lewinski,M., Ciuffi,A., Barr,S., Leipzig,J., Hannenhalli,S. and Hoffmann,C. (2005) Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol., 3, 848-858.
28. Schroder,A.R., Shinn,P., Chen,H., Berry,C., Ecker,J.R. and Bushman,F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110, 521-529.
29. Wu,X., Li,Y., Crise,B. and Burgess,S.M. (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science, 300, 1749-1751.
30. Kang,Y., Moressi,C.J., Scheetz,T.E., Xie,L., Tran,D.T., Casavant,T.L., Ak,P., Benham,C.J., Davidson,B.L. and McCray,P.B. Jr. (2006) Integration Site Choice of a Feline Immunodeficiency Virus Vector. J. Virol., 80, 8820.
31. Crise,B., Li,Y., Yuan,C., Morcock,D.R., Whitby,D., Munroe,D.J., Arthur,L.O. and Wu,X. (2005) Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J. Virol., 79, 12199-12204.
32. MacNeil,A., Sankale,J.L., Meloni,S.T., Sarr,A.D., Mboup,S. and Kanki,P. (2006) Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: Similarities to HIV-1 in vitro and possible differences in vivo. J. Virol., 80, 7316-7321.
33. Hacker,C.V., Vink,C.A., Wardell,T.W., Lee,S., Treasure,P., Kingsman,S.M., Mitrophanous,K.A. and Miskin,J.E. (2006) The integration profile of EIAV-based vectors. Mol. Ther., 14, 536-545.
34. Mitchell,R.S., Beitzel,B.F., Schroder,A.R., Shinn,P., Chen,H., Berry,C.C., Ecker,J.R. and Bushman,F.D. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol., 2, E234.
35. Trobridge,G.D., Miller,D.G., Jacobs,M.A., Allen,J.M., Kiem,P., Kaul,R. and Russell,D.W. (2006) Foamy virus vector integration sites in normal human cells. Proc. Natl Acad. Sci. USA, 103, 1498-1503.
36. Nowrouzi,A., Dittrich,M., Klanke,C., Heinkelein,M., Rammling,M., Dandekar,T., von Kalle,C. and Rethwilm,A. (2006) Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol., 87, 1339-1347.
37. Engelman,A. and Cherepanov,P. (2008) The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathog., 4, c1000046.
38. Cherepanov,P., Maertens,G., Proost,P., Devreese,B., Van Beeumen,J., Engelborghs,Y., De Clercq,E. and Debyser,Z. (2003) HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem., 278, 372-381.
39. Emiliani,S., Mousnier,A., Busschots,K., Maroun,M., Van Maele,B., Tempe,D., Vandekerekhove,L., Moisant,F., Ben-Slama,L., Witvrouw,M. et al. (2005) Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J. Biol. Chem., 280, 25517-25523.
40. Cherepanov,P., Ambrosio,A.L., Rahman,S., Ellenberger,T. and Engelman,A. (2005) Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl Acad. Sci. USA, 102 17308-17313.
41. Vandekerckhove,L., Christ,F., Van Maele,B., De Rijck,J., Gijsbers,R., Van den Haute,C., Witvrouw,M. and Debyser,Z. (2006) Transient and stable knockdown of the integrase cofactor LEDGF/pT5 reveals its role in the replication cycle of human immunodeficiency virus. J. Viral., 80, 1886-1896.
42. Llano,M., Saenz,D.T., Meehan,A., Wongthida,P., Peretz,M., Walker,W.H., Teo,W. and Poeschla,E.M. (2006) An essential role for LEDGF/p75 in HIV integration. Science, 314, 461-464.
43. Shun.M.C., Raghavendra,N.K., Vandegraaff,N., Daigle.J.E., Hughes,S., Kellam,P., Cherepanov,P. and Engelman,A. (2007) LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev., 21, 1767-1778.
44. Ciuffi,A., Llano.M. Poeschla.E., Hoffmann,C., Leipzig,J., Shinn.P., Ecker,J.R. and Bushman,F. (2005) A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med., 11, 1287-1289.
45. Marshall,H.M., Ronen,K., Berry,C., Llano,M., Sutherland,H., Saenz,D., Bickmore,W., Poeschla,E. and Bushman,F.D. (2007) Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS ONE, 2, e1340.
46. Xie,W., Gai,X., Zhu,Y., Zappulla,D.C., Sternglanz,R. and Voytas,D.F. (2001) Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p. Mol. Cell. Biol., 21, 6606-6614.
47. Leem,Y.E., Ripmaster,T.L., Kelly,F.D., Ebina,H., Heincelinan,M.E., Zhang,K., Grewal,S.I., Hoffman,C.S. and Levin,H.L. (2008) Retrotransposon Tf1 is targeted to Pol II promoters by transcription activators. Mol. Cell, 30, 98-107.
48. Moebes,A., Enssle,J., Bieniasz,P.D., Heinkelein,M., Lindemann,D., Bock,M., McClure,M.O. and Rethwilm,A. (1997) Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol., 71, 7305-7311.
49. Walker,P.A., Leong,L.E., Ng,P.W., Tan,S.H., Waller,S., Murphy,D. and Porter,A.G. (1994) Efficient and rapid affinity purification of proteins using recombinant fusion proteases. Biotechnology, 12, 601-605.
50. Cherepanov, P.P. and Wackernagel,W. (1995) Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flpcatalyzed excision of the antibiotic-resistance determinant. Gene, 158 9-14.
51. Trobridge,G., Josephson,N., Vassilopoulos,G., Mac,J. and Russell,D.W. (2002) Improved foamy virus vectors with minimal viral sequences, Mol. Ther., 6, 321-328.
52. Leslie,A.G.W. (1992) Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography.
53. Collaborative Computional Project (1994) The CCP4 suite. programs for protein crystallography. Acta Crystallogr. D. Biol. Crystallogr., 50, 760-763.
54. Evans,P. (2006) Scaling and assessment of data quality. Acta Crystallogr. D. Biol. Crystallogr., 62, 72-82.
55. McCoy,A.J., Grosse-Kunstleve,R.W., Adams,P.D., Winn,M.D., Storoni,L.C. and Read,R.J. (2007) Phaser crystallographic software. J. Appl. Cryst., 40, 658-674.
56. Lubkowski,J., Dauter,Z., Yang,F., Alexandratos,J., Merkel,G., Skalka,A.M. and Wlodawer,A. (1999) Atomic resolution structures of the core domain of avian sarcoma virus integrase and its D64N mutant. Biochemistry, 38, 13512-13522.
57. Sheldrick,G.M. (2008) A short history of SHELX. Acta Crystallogr. A. 64, 112-122.
58. Bricogne,G., Vonrhein,C., Flensburg,C., Schiltz,M. and Paciorek,W. (2003) Generation representation and flow of phase information in structure determination: Recent developments in and around SHARP 2.0. Acta Crystallogr. D. Biol. Crystallogr., 59, 2023-2030.
59. Abrahams,J.P. and Leslic,A.G. (1996) Methods used in the structure determination of bovine mitochondrial F1 ATPasc. Acta Cryslallogr. D. Biol. Crystallogr., 52, 30-42.
60. Perrakis,A., Morris,R. and Lamzin,V.S. (1999) Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol., 6, 458-463.
61. Emsley,P. and Cowtan,K. (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr., 60, 2126-2132.
62. Adams,P.D., Grosse-Kunstleve,R.W., Hung,L.W., Ioerger,T.R., McCoy,A.J., Moriarty,N.W., Read,R.J., Sacchettini,J.C., Sauter,N.K. and Terwilliger,T.C. (2002) PHENIX: Building new software for automated crystallographic structure determination. Acta Crystallogr. D. Biol. Crystallogr., 58, 1948-1954.
63. Murshudov,G.N., Vagin,A.A. and Dodson,E.J. (1997) Refinement of macromolecular structures bv the maximum-likelihood method. Acta Crystallogr. D. Biol. Crystallogr., 53, 240-255.
64. Pfrepper,K.I., Rackwitz,H.R., Schnolzer,M., Heid,H., Lochelt,M. and Flugel,R.M. (1998) Molecular characterization of protcolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease. J. Virol., 72, 7648-7652.
65. Pahl,A. and Flugel,R.M. (1993) Endonuclcolytic cleavages and DNA-joining activities of the integration protein of human foamy virus. J. Virol. 67, 5426-5434.
66. Pahl,A. and Flugel,R.M. (1995) Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1. J. Biol. Chem., 270, 2957-2966.
67. Sato,M., Motomura,T., Aramaki,H., Matsuda,T., Yamashita,M., Ito,Y., Kawakami,H., Matsuzaki,Y., Watanabe,W., Yamataka,K. et al. (2006) Novel HIV-1 integrase inhibitors derived from quinolone antibiotics. J. Med. Chem., 49, 1506-1508.
68. Summa,V., Petrocchi,A., Bonelli,F., Crescenzi,B., Donghi,M., Ferrara,M., Fiore,F., Gardelli,C., Gonzalez Paz,O., Hazuda,D.J. et al. (2008) Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIVAIDS infection. J. Med. Chem., 51, 5843-5855.
69. Chen,J.C., Krucinski,J., Mierckc,L.J., Finer-Moore,J.S., Tang,A.H., Leavitt,A.D. and Stroud,R.M. (2000) Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding. Proc. Natl Acad. Sci. USA, 97, 8233-8238.
70. Chen,Z., Yan,Y., Munshi,S., Li,Y., Zugay-Murphy,J., Xu,B., Witmer,M., Felock,P., Wolfe,A., Sardana,V. et al. (2000) X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)-an initial glance of the viral DNA binding platform. J. Mol. Biol., 296, 521-533.
71. Yang,Z.N., Mueser,T.C., Bushman,F.D. and Hyde,C.C. (2000) Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. J. Mol. Biol., 296, 535-548.
72. Lee,H.S., Kang,S.Y. and Shin,C.G. (2005) Characterization of the functional domains of human foamy virus integrase using chimeric integrases. Mol. Cells, 19, 246-255.
73. Delelis,O., Petit,C., Leh,H., Mbemba,G., Mouscadet,J.F. and Sonigo,P. (2005) A novel function for spumaretrovirus integrase: An early requirement for integrase-mediated cleavage of 2 LTR circles. Retrovirology, 2, 31.
74. Heinkelein,M., Pietschmann,T., Jarmy,G., Dressler,M., Imrich,H., Thurow,J., Lindemann,D., Bock,M., Moebes,A., Roy,J. et al. (2000 Efficient intracellular retrotransposition of an exogenous primite retrovirus genome. EMBO J., 19, 3436-3445.
75. Cherepanov,P., Surratt,D., Toelen,J., Pluymers,W., Griffith,J., De Clereq,E. and Debyser,Z. (1999) Activity of recombinant HIV-1 integrase on mini-HIV DNA. Nucleic Acids Res., 27, 2202-2210.
76. Delelis,O., Carayon,K., Guiot,E., Leh,H., Tauc,P., Brochon,J.C., Mouscadet,J.F. and Deprez,E. (2008) Insight into the integraseDNA recognition mechanism. A specific DNA-binding mode revealed by an enzymatically labeled integrase. J. Biol. Chem., 283, 27838-27849.
77. Li,M., Mizuuchi,M., Burke,T.R. Jr. and Craigie,R. (2006) Retroviral DNA integration: Reaction pathway and critical intermediates. EMBO J., 25, 1295-1304.
78. Faure,A., Calmels,C., Desjobert,C., Castroviejo,M., Caumont-Sarcos, A., Tarrago-Litvak,L., Litvak,S. and Parissi,V. (2005) HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res., 33, 977-986.
79. Pandey,K.K., Bera,S., Zahm,J., Vora,A., Stillmock,K., Hazuda,D. and Grandgenett,D.P. (2007) Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate. J. Virol., 81, 12189-12199.
80. Hombrouck,A., Voet,A., Van Remoortel,B., Desadeleer,C., De Maeyer,M., Debyser,Z. and Witvrouw,M. (2008) Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. Antimicrob. Agents Chemother., 52, 2069-2078.
81. Shafer,R.W. and Schapiro,J.M. (2008) HIV-1 drug resistance mutations: An updated framework for the second decade of HAART. AIDS Rev., 10 67-84.
82. Tobaly-Tapiero,J., Bittoun,P., Lehmann-Che,J., Delelis,O., Giron,M.L., de The,H. and Saib,A. (2008) Chromatin tethering of incoming foamy virus by the structural Gag protein. Traffic, 9, 1717-1727.
83. Crooks,G.E., Hon,G., Chandonia,J.M. and Brenner,S.E. (2004) WebLogo: A sequence logo generator. Genome Res., 14, 1188-1190.
84. Gouet,P., Courcelle,E., Stuart,D.I. and Metoz,F. (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics, 15, 305-308.